2--1--35--3--4--4-3-5--14-124- Polymorphic form of the tachykinin receptor antagonist 2-R-1-R-35-bistrifluoromethylphenylethoxy-3-S-4-fluorophenyl-4-3-5-oxo-1H4H-124-triazolomethylmorpholine

摘要

The present invention is the central nervous system diseases, inflammatory diseases, pain or migraine, useful in the treatment or prevention of asthma and vomiting tachykinins receptor antagonist compound 2- (R) - (1- (R) - (3,5- bis a (trifluoromethyl) phenyl) ethoxy) -3- (S) - (4-fluoro) phenyl-4- (3-5 (-oxo -1H, 4H-1,2,4- triazolo) methyl know relates to a novel polymorphic form of the polymorphic morpholine-type pharmaceutical formulation when included in other known forms of 2- (R) -. (1- (R) - (3,5- bis ( trifluoromethyl) phenyl) ethoxy) -3- (S) - (4-fluoro) phenyl-4- (3-5 (-oxo -1H, 4H-1,2,4- triazolo) methylmorpholine morpholin than is advantageous in the thermodynamic stability and suitability surface